Introduction {#s1}
============

The nematode *Caenorhabditis elegans* has been invaluable for identifying mechanisms that slow aging and may prevent chronic disease ([@bib46]). An intriguing finding that was first made in this organism is that when germline stem cells (GSCs) are ablated, mechanisms are activated in somatic tissues that protect against stress and increase lifespan ([@bib41]; [@bib46]; [@bib6]; [@bib37]). GSC loss also increases lifespan in *Drosophila melanogaster* ([@bib25]), and castration has been associated with longevity in men ([@bib66]), suggesting that this relationship might be conserved. These beneficial effects of GSC removal may have evolved to maximize reproductive fitness under adversity ([@bib85]; [@bib46]). This relationship provides paradigms for how tissue non-autonomous signals influence aging ([@bib46]), and how a stem cell population communicates with the 'niche' that sustains it ([@bib43]).

In *C. elegans*, the effects of GSC absence have been studied by laser ablation of GSC precursors, which results in a complete loss of GSCs, or by analysis of genetic mutants in which GSC proliferation is inhibited so that the GSC number is very low, and mature germ cells are not formed ([@bib41]; [@bib7]; [@bib46]). For simplicity, we will refer to each of these types of animals as GSC(−) animals. The lifespan extension seen in GSC(−) animals (GSC(−) longevity) requires the action of several conserved transcription factors in the intestine, the counterpart of the mammalian liver, digestive system, and adipose tissue ([@bib46]; [@bib6]; [@bib37]). DAF-16/FOXO is needed for longevity from GSC ablation or reduced insulin/IGF-1 signaling (IIS) but is regulated differently by each pathway ([@bib61]; [@bib59]; [@bib46]). GSC(−) longevity also requires HLH-30/TFEB, PHA-4/FOXA, and the nuclear receptors DAF-12/FXR, NHR-80/HNF4, and NHR-49/PPARα ([@bib41]; [@bib34]; [@bib51]; [@bib77]; [@bib91]). Under most conditions, GSC(−) longevity also depends upon a hormonal signal from the somatic gonad that activates DAF-12 ([@bib46]; [@bib6]). Aside from the identification of mechanisms required for DAF-16 function, we understand little about how GSCs influence these transcription factors ([@bib46]; [@bib6]).

One hallmark of GSC(−) animals is enhancement of both proteostasis and stress resistance. During aging, GSC(−) animals maintain more robust responses to thermal and proteotoxic stress ([@bib8]). They also exhibit a striking *daf-16*-dependent increase in activity of the proteasome ([@bib109]), a multisubunit complex which degrades proteins that the ubiquitylation system has tagged for decay ([@bib32]; [@bib33]). In addition, GSC removal enhances immunity ([@bib3]) and boosts oxidative stress resistance through an undetermined DAF-16-independent mechanism ([@bib59]).

Another notable characteristic of GSC(−) animals is that many aspects of lipid metabolism are altered. Expression of particular fatty acid (FA) oxidation, FA desaturation, and triglyceride lipase genes is increased, as is total lipase activity ([@bib110]; [@bib34]; [@bib51]; [@bib64]; [@bib91]). Given that lipid catabolism is elevated, it seems paradoxical that GSC(−) animals also exhibit dramatically increased fat accumulation ([@bib78]). Interestingly, GSC(−) longevity seems to depend upon particular lipid metabolism processes. Production of the unsaturated free FA (FFA) oleic acid (OA) is required ([@bib34]), as are the triglyceride lipases LIPL-4/LIPA and FARD-1/FAR2 ([@bib110]; [@bib64]). It is of intense interest to determine whether the fat accumulation seen with GSC ablation might derive from production and storage of particular beneficial fats, or a salutary overall balance of lipid metabolism that is consistent with longevity ([@bib1]; [@bib37]).

The *C. elegans* transcription factor SKN-1 controls a broad detoxification response to oxidative and xenobiotic stress and is orthologous to the mammalian Nrf1/2/3 (NF-E2-related factor) proteins ([@bib4]; [@bib80]; [@bib84]). SKN-1/Nrf proteins have been implicated in longevity from *C. elegans* to rodents ([@bib4]; [@bib11]; [@bib55]; [@bib106]; [@bib104]; [@bib24]). Recent findings raise the question of whether these transcription regulators might also have important functions in lipid homeostasis. SKN-1/Nrf proteins influence expression of lipid metabolism genes ([@bib80]; [@bib82]; [@bib38]; [@bib107]), and SKN-1 has been linked to fat mobilization under particular starvation or dietary conditions ([@bib82]; [@bib83]). Mice that lack Nrf1 in the liver develop non-alcoholic fatty liver disease (NAFLD) that progresses to non-alcoholic steatohepatitis (NASH), and Nrf2^−/−^ mice develop NASH on a high-fat diet ([@bib112]; [@bib79]; [@bib107]). However, reduced Nrf protein function is thought to predispose to NASH by impairing hepatic stress resistance ([@bib112]; [@bib54]). An understanding of NAFLD is a high priority, because its incidence is increasing as a sequella of metabolic syndrome ([@bib17]).

Here, we examined the role of SKN-1 in the effects of GSC absence on lifespan, stress resistance, and lipid metabolism. Genetic inhibition of GSCs activates SKN-1, thereby increasing lifespan and stress resistance. Expression profiling revealed that GSC(−) animals upregulate stress defense, extracellular matrix, and lipid metabolism genes, in many cases dependent upon *skn-1*. SKN-1 is also required for GSC inhibition to increase proteasome activity. SKN-1 is needed for GSC(−) longevity but reduces lipid storage, arguing against the idea that GSC(−) animals simply accumulate beneficial fat. Instead, these high-fat levels appear to derive from unconsumed yolk that was produced for reproduction. Unexpectedly, in GSC(−) animals, SKN-1 appears to be activated by specific FA signals, defining a new mechanism of SKN-1/Nrf protein regulation and GSC-to-soma communication. This homeostatic function of SKN-1 in lipid metabolism suggests that Nrf proteins have a similar role in preventing NASH.

Results {#s2}
=======

SKN-1 promotes longevity and stress resistance in the absence of GSCs {#s2-1}
---------------------------------------------------------------------

To investigate the importance of *skn-1* in GSC(−) animals, we analyzed temperature-sensitive (ts) mutations in *glp-1*/Notch, which is required for GSC proliferation ([@bib47]). *glp-1(ts)* mutants that undergo larval development at the non-permissive temperature of 25°C (GSC(−) animals) are sterile, exhibit a markedly reduced number of GSCs, and live considerably longer than wild type (WT) controls ([@bib7]) ([Figure 1A,B](#fig1){ref-type="fig"}). By contrast, this lifespan extension was blocked in a *skn-1* mutant background ([Figure 1A,B](#fig1){ref-type="fig"}). Lack of *skn-1* also impaired lifespan extension when *glp-1(ts)* animals were downshifted to 20°C after development was complete ([Table 1](#tbl1){ref-type="table"}). Similar results were obtained with or without 5-fluoro-2′-deoxyuridine (FUdR), which inhibits offspring formation in the control ([Table 1](#tbl1){ref-type="table"}). Consistent with these findings, in an earlier experiment in which *glp-1(ts)* extended lifespan by less than 7%, *skn-1* knockdown by RNA interference (RNAi) prevented this increase ([@bib109]). In contrast to *daf-16, skn-1* was also required for GSC inhibition to increase oxidative stress resistance ([Figure 1C--F](#fig1){ref-type="fig"}; [Table 2](#tbl2){ref-type="table"}).10.7554/eLife.07836.003Figure 1.SKN-1 promotes longevity and stress resistance in germline stem cell (GSC)(−) animals.(**A**, **B**) Wild type, *skn-1(zu135), glp-1(bn18ts)*, and *glp-1(bn18ts);skn-1(zu135)* double mutants were assayed for lifespan at 25°C. *skn-1(zu135)* is a presumed null that is used throughout the study. Unless otherwise specified, *glp-1(ts)* refers to *glp-1(bn18ts)*. (**A**) Composite survival curve. (**B**) Graph of mean lifespans. (**C**--**F**) *glp-1(ts)* mutants require *skn-1* for oxidative stress resistance. Day-3 adult *glp-1(ts)* and control worms treated with *skn-1* RNAi or empty vector were exposed to (**C**, **D**) 5 mM sodium arsenite (AS) or (**E**, **F**) 15.4 mM tert-butyl hydroperoxide (TBHP). Data are represented as mean ± SEM. p \< 0.001\*\*\*. The interaction between *glp-1* and *skn-1* was significant for both lifespan and stress resistance (p \< 0.001). Statistical analysis and replicates are in [Tables 1](#tbl1){ref-type="table"}, [2](#tbl2){ref-type="table"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.003](10.7554/eLife.07836.003)10.7554/eLife.07836.004Table 1.Lifespans**DOI:** [http://dx.doi.org/10.7554/eLife.07836.004](10.7554/eLife.07836.004)SetStrainMean lifespan ± SEM (days)Median lifespan (days)75th % (days)N% Mean lifespan Ext.p valueLifespan at 25°C Composite lifespan at 25°C with FUdR (from 2 replicates)C1N215.40 ± 0.21617133/148----*skn-1(zu135)*14.66 ± 0.21516158/167----*glp-1(bn18ts)*19.94 ± 0.32022164/17129.48\<0.0001\**glp-1(bn18ts);skn-1(zu135)*15.23 ± 0.21518149/1703.89\<0.0001†two-way ANOVA *glp-1(ts)* and *skn-1* interaction\<0.0001 Replicate lifespans at 25°C with FUdR\#1N213.99 ± 0.4141740/55----*skn-1(zu135)*12.54 ± 0.3131441/50----*glp-1(bn18ts)*22.46 ± 0.8252750/5560.54\<0.0001\**glp-1(bn18ts);skn-1(zu135)*13.29 ± 0.4121453/706.00\<0.0001†*glp-1(ts)* and *skn-1* interaction\<0.0001 \#2N216.07 ± 0.2161793/93----*skn-1(zu135)*15.42 ± 0.21517117/117----*glp-1(bn18ts)*18.86 ± 0.31921114/11617.36\<0.0001\**glp-1(bn18ts);skn-1(zu135)*16.42 ± 0.2171896/1006.49\<0.0001†*glp-1(ts)* and *skn-1* interaction0.0002Lifespan at 20°C (25°C during development, downshifted to 20°C at D1 adulthood) Lifespan at 20°C without FUdR\#3N220.36 ± 0.6182142/50----*skn-1(zu135)*18.39 ± 0.5181827/47----*glp-1(bn18ts)*25.87 ± 1.3243335/6627.060.0002\**glp-1(bn18ts);skn-1(zu135)*20.02 ± 0.6182434/558.86\<0.0001†*glp-1(ts)* and *skn-1* interaction0.0230 Composite lifespan at 20°C with FUdR (from 2 replicates)C2N220.51 ± 0.5212486/90----*skn-1(zu135)*17.78 ± 0.4192088/94----*glp-1(bn18ts)*24.52 ± 0.6252881/10419.55\<0.0001\**glp-1(bn18ts);skn-1(zu135)*20.47 ± 0.5202491/9815.13\<0.0001†*glp-1(ts)* and *skn-1* interaction0.1892  Replicate lifespans at 20°C with FUdR\#4N218.09 ± 0.4171933/37----*skn-1(zu135)*14.78 ± 0.5141731/35----*glp-1(bn18ts)*21.79 ± 1.0212828/5020.450.0002\**glp-1(bn18ts);skn-1(zu135)*16.83 ± 0.3171836/4313.87\<0.0001†*glp-1(ts)* and *skn-1* interaction0.1491\#5N222.00 ± 0.6232553/53----*skn-1(zu135)*19.40 ± 0.4202157/59----*glp-1(bn18ts)*25.91 ± 0.7253053/5417.77\<0.0001\**glp-1(bn18ts);skn-1(zu135)*22.80 ± 0.6242655/5517.53\<0.0001†*glp-1(ts)* and *skn-1* interaction0.6607[^2]10.7554/eLife.07836.005Table 2.Stress resistance assays**DOI:** [http://dx.doi.org/10.7554/eLife.07836.005](10.7554/eLife.07836.005)SetStrainMean survival ± SEM (hrs)Median survival (hrs)75th % survival (hrs)N% Mean survival Ext.p valueAS (day 1 adulthood) 25°C continuous; RNAi from L1 \#1N2 + vector RNAi20.20 ± 1.022.522.5122/122----N2 + *rme-2* RNAi39.51 ± 1.147.547.5117/11795.59\<0.0001\* \#2N2 + vector RNAi26.82 ± 1.228.028.057/57----N2 + *rme-2* RNAi53.21 ± 0.952.571.5252/25298.44\<0.0001\**glp-1(bn18ts)* + vector RNA53.06 ± 1.052.571.5216/21697.85\<0.0001\* \#3N2 + vector RNAi (**20°C**)38.59 ± 0.647.547.5281/281----N2 + *rme-2* RNAi63.00 ± 0.771.571.5287/28763.25\<0.0001\* \#4N2 + vector RNAi (**20°C**)49.10 ± 0.846.064.0306/306----N2 + vector/*skn-1* mix RNAi32.03 ± 0.640.040.0271/271----N2 + vector/*rme-2* mix RNAi65.38 ± 1.164.070.0361/36133.16\<0.0001\*N2 + *rme-2*/*skn-1* mix RNAi33.76 ± 0.540.040.0409/4095.40\<0.0001‡two-way ANOVA *rme-2* and *skn-1* interaction\<0.0001 \#5N2 + vector RNAi23.18 ± 0.522.522.5125/125----N2 + *lipl-3* RNAi23.04 ± 0.622.528.0139/139----N2 + *sbp-1* RNAi11.01 ± 0.67.522.5163/163----N2 + *skn-1* RNAi20.88 ± 0.722.528.0115/115----*glp-1(bn18ts)* + vector RNAi40.58 ± 1.147.547.5105/10575.05\<0.0001\**glp-1(bn18ts)* + *lipl-3* RNAi28.52 ± 1.028.032.5178/17823.77\<0.0001†*glp-1(bn18ts)* + *sbp-1* RNAi7.50 ± 0.56.07.5138/138−31.88\<0.0001†*glp-1(bn18ts)* + *skn-1* RNAi12.90 ± 0.99.022.5129/129−38.21\<0.0001†*glp-1(ts)* and *lipl-3* interaction\<0.0001*glp-1(ts)* and *sbp-1* interaction\<0.0001*glp-1(ts)* and *skn-1* interaction\<0.0001 \#6N2 + vector RNAi24.36 ± 0.822.528.0121/121----N2 + *fat-6/7* mix RNAi15.56 ± 0.822.522.5159/159----N2 + *skn-1* RNAi20.94 ± 0.622.522.5124/124----*glp-1(bn18ts)* + vector RNAi38.49 ± 1.547.547.598/9858.03\<0.0001\**glp-1(bn18ts)* + *fat-6/7* mix RNAi12.04 ± 0.79.022.5153/153−22.66\<0.0001†*glp-1(bn18ts)* + *skn-1* RNAi23.69 ± 0.928.032.5116/11613.13\<0.0001†*glp-1(ts)* and *fat-6/7* interaction\<0.0001*glp-1(ts)* and *skn-1* interaction\<0.0001AS (day 3 adulthood) 25°C during development, 20°C from D1; RNAi from D1 \#7N2 + vector RNAi6.55 ± 0.37.08.0104/104----N2 + *skn-1* RNAi5.08 ± 0.25.07.0103/103----*glp-1(bn18ts)* + vector RNAi19.36 ± 0.119.020.097/97195.57\<0.0001\**glp-1(bn18ts) + skn-1* RNAi7.86 ± 0.48.012.0100/10054.72\<0.0001†*glp-1(ts)* and *skn-1* interaction\<0.0001 \#8N2 + vector RNAi8.31 ± 0.49.010.098/98----N2 + *skn-1* RNAi6.89 ± 0.38.09.090/90----*glp-1(bn18ts)* + vector RNAi16.95 ± 1.020.026.081/81103.97\<0.0001\**glp-1(bn18ts) + skn-1* RNAi9.90 ± 0.410.012.091/9143.69\<0.0001†*glp-1(ts)* and *skn-1* interaction\<0.0001TBHP (day 3 adulthood) 25°C during development, 20°C from D1; RNAi from D1 \#9N2 + vector RNAi9.02 ± 0.39.011.084/108----N2 + *skn-1* RNAi6.16 ± 0.26.07.063/98----*glp-1(bn18ts)* + vector RNAi11.62 ± 0.311.013.061/6128.82\<0.0001\**glp-1(bn18ts) + skn-1* RNAi6.48 ± 0.18.07.063/655.19\<0.0001†*glp-1(ts)* and *skn-1* interaction\<0.0001 \#10N24.29 ± 0.24.04.065/94----*skn-1(zu135)*4.51 ± 0.15.03.073/74----*glp-1(bn18ts)*6.25 ± 0.26.04.073/7445.69\<0.0001\**glp-1(bn18ts);skn-1(zu135)*4.78 ± 0.15.04.073/755.99\<0.0001†*glp-1(ts)* and *skn-1* interaction\<0.0001[^3]

GSCs regulate intestinal DAF-16 and SKN-1 through different mechanisms {#s2-2}
----------------------------------------------------------------------

We investigated whether the benefits of GSC absence simply require that SKN-1 be present or involve activation of SKN-1. SKN-1 accumulates in intestinal nuclei in response to certain stresses, or inhibition of mechanisms that include IIS, mTORC2, glycogen synthase kinase-3, translation elongation, and the ubiquitin ligase WDR-23 ([@bib4]; [@bib108]; [@bib15]; [@bib84]; [@bib56]; [@bib93]). The levels of a SKN-1::GFP (green fluorescent protein) fusion in intestinal nuclei were also notably elevated in GSC(−) animals ([Figure 2A,B](#fig2){ref-type="fig"}). This was associated with increased expression of direct SKN-1 target genes, apparently through activation of their intestinal expression ([Figure 2C--E](#fig2){ref-type="fig"}). The KRI-1/KRIT1 ankyrin repeat protein and the TCER-1/TCERG1 transcription factor are required for GSC absence to induce DAF-16 nuclear accumulation and extend lifespan ([@bib10]; [@bib31]). In contrast, in GSC(−) animals SKN-1 nuclear accumulation was only partially or minimally affected by loss of *kri-1* or *tcer-1*, respectively, but was abolished by knockdown of the *pmk-1*/p38 kinase ([Figure 2F,G](#fig2){ref-type="fig"}), which phosphorylates SKN-1 and under most circumstances is required for SKN-1 nuclear accumulation ([@bib42]). In GSC(−) animals, DAF-12 is needed for DAF-16 nuclear accumulation and activity ([@bib10]; [@bib46]; [@bib6]), and induces expression of the microRNAs *mir-84* and *mir-241*, which target inhibitors of DAF-16 ([@bib99]). In GSC(−) animals, *daf-12* knockdown only mildly affected SKN-1::GFP accumulation ([Figure 2G](#fig2){ref-type="fig"}), and SKN-1 target gene induction was generally not impaired by *daf-12* or *mir-241;mir-84* mutations ([Figure 2H](#fig2){ref-type="fig"}). The absence of GSCs therefore activates SKN-1 in the intestine but through a different mechanism from DAF-16.10.7554/eLife.07836.006Figure 2.GSCs inhibit SKN-1 activity in the intestine.(**A**) Representative images of SKN-1::green fluorescent protein (GFP) in intestinal nuclei; GFP channel (top), bright field (BF; bottom). (**B**) Accumulation of SKN-1::GFP in intestinal nuclei in GSC(−) animals. (**C**) *skn-1*-dependent activation of direct SKN-1 target genes ([@bib93]) in response to GSC absence, detected by qRT-PCR. (**D**, **E**) Increased expression of *gst-4p*::GFP in the intestine of *glp-1(ts)* animals. Hypodermal *gst-4p*::GFP expression appeared to be unaffected. (**D**) Representative 10× images. (**E**) Intestinal *gst-4p*::GFP quantification. (**F**--**H**) GSCs regulate SKN-1 parallel to DAF-16 and DAF-12. In (**H**), SKN-1 target genes are assayed by qRT-PCR. *glp-1(ts)* refers to *glp-1(e2141ts)*, and horizontal black lines indicate strains lacking GSCs. (**C**, **H**) Data are represented as mean ± SEM. n = 3 for qRT-PCR samples. (**B**, **E**--**G**) GFP quantification with high, medium, low scoring. Numbers above bars denote sample size. p \< 0.05\*; p \< 0.01\*\*; p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.006](10.7554/eLife.07836.006)

SKN-1 reprograms stress resistance and metabolism in GSC(−) animals {#s2-3}
-------------------------------------------------------------------

To investigate how SKN-1 promotes longevity and stress resistance upon GSC loss, we used RNA sequencing (RNA-seq) to identify genes that are (1) expressed at higher levels in adult somatic tissues when germ cells are largely absent and (2) dependent upon SKN-1 ([Figure 3A](#fig3){ref-type="fig"}). We compared intact *glp-1(ts)* (GSC(−)) animals to wild-type GSC(+) controls at the non-permissive temperature of 25°, analyzing day-1 adults in which development was complete and performing differential expression analyses on the normalized RNA-seq data for 12,595 expressed genes ([Figure 3B](#fig3){ref-type="fig"}). We detected similar expression levels of SKN-1 upregulated targets in qRT-PCR analyses of the samples used for sequencing, giving us confidence in our RNA-seq results ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Moreover, in the GSC(−) gene set, the canonical DAF-16 targets *mtl-1* and *sod-3* ([@bib71]; [@bib46]) were upregulated ([Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}), and functional groups that are characteristic of germline-specific genes were under-represented ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).10.7554/eLife.07836.007Figure 3.Effects of GSC absence and *skn-1* on gene expression.(**A**) RNA-seq experiment setup. For each condition, three biological replicates were obtained from synchronized intact day-1 adults at 25°C. Arrows indicate comparisons that were made, and GSC(−) refers to *glp-1(ts)*. (**B**) Heatmap of all genes evaluated, showing biological replicates. (**C**) DAVID functional annotation analysis of GSC(−)-upregulated genes. (**D**) Heatmap of genes upregulated in *glp-1(ts)* in a *skn-1*-dependent manner (87 genes; fold change (FC) \> 4 in GSC(−); FC \< 0.67 with *skn-1* RNAi in GSC(−)). (**E**) Functional annotation of the genes shown in (**D**). Genes and additional statistics are provided in [Supplementary file 1a,d](#SD1-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.007](10.7554/eLife.07836.007)10.7554/eLife.07836.008Figure 3---figure supplement 1.Gene expression changes following GSC inhibition.(**A**) qRT-PCR validation of RNA samples used for RNA-seq. *gst-4* and *nit-1* are direct SKN-1 targets ([@bib93]). Data are represented as mean ± SEM. n = 3; p \< 0.05\*. Analysis of a different RNA sample set is shown in [Figure 2D](#fig2){ref-type="fig"}. (**B**) DAVID analysis of genes that were downregulated in *glp-1(ts)*. Processes related to GSC maintenance and reproduction were highly represented, as expected. (**C**) Altered abundance of tissue-specific genes in GSC(−) animals. Adult hermaphrodite worms have 959 somatic cells and ∼2000 GSCs ([@bib47]). A representative somatic-specific gene would therefore be predicted to be present at higher relative abundance in GSC(−) samples after normalization to either total RNA or reference housekeeping genes. Accordingly, representative somatic tissue-specific genes ([@bib92]; [@bib69]; [@bib14]) were present at threefold to fourfold higher relative levels in the GSC(−) samples. By contrast, a germline-specific gene (*efl-1*) was underrepresented (∼4×) in GSC(−) samples. Reference genes that are ubiquitously expressed in all tissues and commonly used for qRT-PCR normalization ([@bib40]) do not have altered relative abundance in the GSC(−) samples. (**D**, **E**) Frequency distribution plots of mRNA levels in *glp-1(ts)* worms relative to wild type. A cutoff of FC \> 4 denotes 1,306 out of 12,595 genes sequenced (10.4%).**DOI:** [http://dx.doi.org/10.7554/eLife.07836.008](10.7554/eLife.07836.008)

No previous studies have globally profiled genes that are upregulated in the soma in response to germ cell loss. mRNAs that are present at higher relative levels in GSC(−) samples compared to WT would include not only those genes, but also genes that are expressed only in somatic cells, because the germline accounts for about two-thirds of all adult nuclei ([@bib47]). To gauge the maximal extent of this background, we examined mRNAs that are expressed specifically in somatic tissues. These somatic-specific mRNAs were enriched threefold to fourfold in the GSC(−) samples, approximately, the level predicted from the 2:1 proportion of germline to somatic nuclei ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Accordingly, if an mRNA that is not somatic specific was present at a fourfold-elevated level in GSC(−) samples, we considered this mRNA to be upregulated in the soma in response to GSC absence, although we expect that this stringent cutoff would miss many upregulated genes.

In GSC(−) animals, 1306 and 615 genes were upregulated more than fourfold and fivefold, respectively, indicating a broad remodeling of transcription ([Figure 3---figure supplement 1D,E](#fig3s1){ref-type="fig"}; [Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}). In the latter set, which is more amenable to functional annotation analysis because of its smaller size, the most prominently overrepresented category was collagen ([Figure 3C](#fig3){ref-type="fig"}; [Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}). Although collagens may be expressed primarily in the soma, this overrepresentation is likely to be meaningful because of the extent to which these genes were upregulated ([Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}), and because collagens are generally overrepresented in other longevity-associated gene sets, with certain collagens being critical for lifespan extension ([@bib24]). Also, notably upregulated in GSC(−) animals were genes involved in detoxification, immunity (C-type lectin and galectin), and metabolism, particularly FA oxidation and other lipid metabolism processes ([Figure 3C](#fig3){ref-type="fig"}; [Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}).

We used RNAi to investigate the contribution of *skn-1* to gene expression in GSC(−) animals ([Figure 3A](#fig3){ref-type="fig"}). A previous microarray analysis of *skn-1* RNAi-treated L4 larvae at 20°C found that in the absence of acute stress, SKN-1 upregulates genes involved in processes that include detoxification, lipid metabolism, immunity, and proteostasis ([@bib80]; [@bib56]). Similar processes were prominent in the sets of genes for which *skn-1* RNAi reduced expression at 25°C in day-1 WT adults ('SKN-1 upregulated in WT genes'; ≥33% reduction, p \< 0.05) ([Supplementary file 1b](#SD1-data){ref-type="supplementary-material"}) or day-1 GSC(−) animals ('SKN-1-upregulated in GSC(−) genes'; ≥33% reduction, p \< 0.05) ([Supplementary file 1c](#SD1-data){ref-type="supplementary-material"}). Our finding that SKN-1 nuclear occupancy is increased in GSC(−) animals ([Figure 2](#fig2){ref-type="fig"}) predicts that GSC inhibition would induce SKN-1 to activate genes. Accordingly, *skn-1* RNAi reduced expression of 87 genes that were upregulated at least fourfold in *glp-1(ts)* compared to WT ([Figure 3D,E](#fig3){ref-type="fig"}; [Supplementary file 1d](#SD1-data){ref-type="supplementary-material"}). This number probably underestimates the full contribution of SKN-1, because RNAi only partially reduces its activity. In addition to detoxification and lipid metabolism genes, these 87 genes included many involved in extracellular matrices (ECMs), as expected from the *skn-1*-dependence of many ECM genes that are upregulated in other long-lived *C. elegans* ([@bib24]). Many of these *skn-1*-dependent GSC(−) genes appear to be direct SKN-1 targets, as predicted by presence of SKN-1 binding sites in their upstream regions and direct binding of SKN-1 in genome-wide chromatin immunoprecipitation (ChIP) surveys ([Supplementary file 1d](#SD1-data){ref-type="supplementary-material"}). In summary, SKN-1 upregulates numerous genes that are associated with phenotypes seen in GSC-ablated animals, including increased stress resistance, immunity, and longevity, as well as alterations in lipid metabolism.

SKN-1 increases proteasome activity in response to GSC loss {#s2-4}
-----------------------------------------------------------

A previous RNAi experiment suggested that SKN-1 is dispensable for the elevated proteasome activity seen in GSC(−) animals ([@bib109]). We re-examined this question because SKN-1 maintains proteasome gene expression and intestinal proteasome activity in WT *C. elegans* ([@bib56]), and because proteasome genes were prominent in the SKN-1-upregulated GSC(−) gene set ([Supplementary file 1c](#SD1-data){ref-type="supplementary-material"}). The proteasome holocomplex consists of a 20S barrel-like structure in which proteins are degraded, and a 19S regulatory cap that directs ubiquitylated proteins into this structure ([@bib32]; [@bib33]). In general, and consistent with previous findings ([@bib109]), the relative levels of proteasome subunit mRNAs were lower in GSC(−) animals ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), possibly because of the lack of germ cells. In both WT and GSC(−) animals, *skn-1* knockdown comparably decreased expression of 19S and 20S proteasome subunit genes ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), the majority of which appear to be direct transcriptional targets of SKN-1 ([Figure 4B](#fig4){ref-type="fig"}). As these findings would predict, in GSC(−) animals, the lack of *skn-1* dramatically reduced proteasome activity at days 1 and 5 of adulthood ([Figure 4C,D](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 1B--G](#fig4s1){ref-type="fig"}). It is possible that in the earlier analysis ([@bib109]), RNAi might not have inhibited *skn-1* expression sufficiently to detect its importance for proteasome activity in GSC(−) animals.10.7554/eLife.07836.009Figure 4.SKN-1 increases proteasome activity in response to GSC absence.(**A**) Reduction in relative proteasome gene subunit mRNA levels by *skn-1* RNAi, detected by RNA-seq. (**B**) Venn diagram indicating the number of proteasome subunit genes (*pas*, *pbs*, *rpn*, *rpt* families) that have SKN-1::GFP ChIP-seq peak hits near the transcription start site at the indicated larval stage ([@bib75]). (**C**, **D**) SKN-1-dependence of increased chymotrypsin-related proteasome activity in GSC-ablated worms. The slopes from (**C**) are graphed in (**D**). Additional experiments are in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. (**E**) SKN-1-dependence of *rpn-6.1* upregulation. Data are represented as mean ± SEM. n = 3 for all experiments. p \< 0.05\*; p \< 0.01\*\*; p \< 0.001\*\*\*. (**F**) Direct binding of SKN-1 and DAF-16 to the *rpn-6.1* gene, indicated by TRANSFAC transcription factor binding prediction and modENCODE GFP ChIP-seq analyses. Both the predicted promoter and first intron of *rpn-6.1* are highly enriched for SKN-1 and DAF-16 binding.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.009](10.7554/eLife.07836.009)10.7554/eLife.07836.010Figure 4---figure supplement 1.SKN-1-dependence of the increased proteasome activity in GSC(−) animals.(**A**) GSC absence reduces relative proteasome subunit gene mRNA abundance, detected by RNA-seq. (**B**, **C**) The *skn-1(zu135)* mutation suppresses the increase in 26S proteasome activity seen in day-1 adult *glp-1(ts)* animals. (**D**, **E**) *skn-1* RNAi administered from the egg stage suppresses proteasome activity in day-1 adult *glp-1(ts)* animals. (**F**, **G**) *skn-1* RNAi administered post-developmentally, starting at day-1 adulthood, significantly reduces proteasome activity in day-5 adult *glp-1(ts)* animals. (**B**, **D**, **F**) Kinetic curves of chymotrypsin-like proteasome activity. (**C**, **E**, **G**) Graphs of proteasome activity slopes. Data are represented as mean ± SEM. n = 3; p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.010](10.7554/eLife.07836.010)

The increased proteasome activity of GSC(−) animals is thought to derive from DAF-16-dependent transcriptional upregulation of the RPN-6.1/PSMD11 subunit, which connects the 19S and 20S proteasome particles ([@bib109]). *rpn-6.1* appears to be unique among proteasome subunit genes, in that its mRNA levels are proportionally higher in GSC(−) animals ([@bib109]) ([Figure 4E](#fig4){ref-type="fig"}). *skn-1* was required for this increased *rpn-6.1* expression ([Figure 4E](#fig4){ref-type="fig"}), and binding site and ChIP studies suggested that *rpn-6.1* is upregulated directly by both SKN-1 and DAF-16 ([Figure 4F](#fig4){ref-type="fig"}). We conclude that by promoting expression of multiple proteasome subunit genes, including *rpn-6.1*, SKN-1 plays a central role in the increased proteasome activity that results from GSC loss.

SKN-1 regulates lipid metabolism {#s2-5}
--------------------------------

Genetic GSC inhibition increased expression of lipid metabolism genes that represent a wide range of processes, including FFA formation from triglyceride lipolysis, as well as FA oxidation, desaturation, and elongation ([Figure 5A](#fig5){ref-type="fig"}; [Supplementary file 1a](#SD1-data){ref-type="supplementary-material"}). Many of these genes were also upregulated by SKN-1 ([Figure 5A](#fig5){ref-type="fig"}; [Supplementary file 1a--c](#SD1-data){ref-type="supplementary-material"}). Of particular note, the high-confidence GSC(−) and SKN-1-upregulated gene set included the conserved lysosomal triglyceride lipase *lipl-3*, which increases *C. elegans* lifespan when overexpressed and is normally induced by fasting ([@bib77]). This gene set also included the FA oxidation genes *acs-*10 (acyl-CoA synthetase), *cpt-3* (carnitine palmitoyltransferase), and *ech-9* (enoyl-CoA hydratase) ([Figure 5A](#fig5){ref-type="fig"}; [Supplementary file 1d](#SD1-data){ref-type="supplementary-material"}). This suggested that SKN-1 might have a major role in lipid metabolism, and how it is influenced by GSC absence.10.7554/eLife.07836.011Figure 5.SKN-1 regulates lipid metabolism in GSC(−) animals.(**A**) Functional map of lipid metabolism gene expression. Left columns show the effects of GSC absence (GSC(−) vs WT) and right columns the effects of *skn-1* RNAi in GSC(−) animals. SKN-1 regulates genes involved in fatty acid (FA) oxidation, breakdown of triacylglycerols (TAG) to free FAs, production of mono- and poly-unsaturated FAs (MUFA, PUFA), and FA transport. Color coding reflects relative representation in RNA-seq data, with blue and yellow indicating increased and decreased expression, respectively. (**B**--**E**) Increased fat levels in *glp-1(ts)* and *skn-1* mutants but not *daf-16* mutants. (**D**, **E**) *glp-1(ts)* refers to *glp-1(e2141ts)*. Representative 40× differential interference contrast (DIC) images of fixed ORO-stained worms are shown in (**B**, **D**), with quantification provided in (**C**, **E**). Additional images and quantification are provided in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. Data are represented as mean ± SEM. Numbers above bars denote sample size. p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.011](10.7554/eLife.07836.011)10.7554/eLife.07836.012Figure 5---figure supplement 1.Representative ORO staining images with quantification.Representative images divided into approximate quintiles, ordered by mean pixel intensity, are shown for each strain. BF images are presented on the left and background subtracted images with quantification on the right. (**A**) *glp-1(bn18ts)* and *skn-1(zu135)* mutants. (**B**) *glp-1(ts)* mutants treated with *skn-1* and *sbp-1* RNAi. Increased staining was observed both with *skn-1* mutants and *skn-1* RNAi. RNAi against *sbp-1*, which is required for lipogenesis ([@bib113]), decreases ORO staining in both WT and *glp-1(ts)* genetic backgrounds. (**C**) *glp-1(e2141ts)* and *daf-16(mu86)* mutants. Numbers indicate mean pixel intensity above background (see 'Materials and methods' for additional details).**DOI:** [http://dx.doi.org/10.7554/eLife.07836.012](10.7554/eLife.07836.012)10.7554/eLife.07836.013Figure 5---figure supplement 2.Analysis of the intestinal lipid droplet marker DHS-3::GFP, and TAG levels.*skn-1* RNAi increases DHS-3::GFP intensity in both wild-type and GSC(−) animals, whereas *sbp-1* RNAi decreases DHS-3::GFP intensity. (**A**) 10× slide-mounted DHS-3::GFP images. White arrows indicate intestine-specific expression. (**B**, **C**) COPAS Biosorter quantification of DHS-3::GFP in live day-1 adult worms. (**B**) Representative 10× inverted scope images of worms suspended in M9 buffer used for COPAS scoring. (**C**) Graph of mean DHS-3::GFP fluorescence, assayed by COPAS. Numbers above bars denote sample size. Asterisks directly above bars indicate p values relative to WT or RNAi control. Asterisks above black lines denote effect of RNAi in *glp-1(ts)* background. RNAi was started from egg stage, and animals were raised at 25°C. (**D**) TAG levels are significantly elevated in *skn-1* mutants. Data are represented as mean ± SEM. p \< 0.01\*\*; p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.013](10.7554/eLife.07836.013)10.7554/eLife.07836.014Figure 5---figure supplement 3.RNA-seq counts of select lipid metabolism and yolk transporter genes.Expression of the known SKN-1 target genes *gst-4* and *nit-1* is elevated in GSC(−) animals in a *skn-1-*dependent manner. The TAG lipase *lipl-3* and FABP *lbp-8* are similarly elevated in GSC(−) animals in a *skn-1*-dependent manner, but expression of *sbp-1*, *dhs-3*, and yolk protein vitellogenins (VIT genes) are not affected by *skn-1* RNAi. *rme-2* expression is germline enriched but regulated independently of *skn-1*. Open circles denote replicates. Vertical lines indicate mean counts per million (CPM).**DOI:** [http://dx.doi.org/10.7554/eLife.07836.014](10.7554/eLife.07836.014)

Given that SKN-1 increases both lifespan and stress resistance in GSC(−) animals, its effects on lipid metabolism should also be beneficial. If the elevated fat storage in GSC(−) animals reflects simply elevated production and storage of 'good' lipids, we might expect *skn-1* to support this fat production. We investigated whether SKN-1 affects fat storage in WT and GSC(−) animals by oil red O (ORO) staining of fixed animals, a method that reliably indicates fat accumulation ([@bib78]). Remarkably, ablation of *skn-1* by either mutation or RNAi significantly increased lipid levels in either WT or GSC(−) day-1 adults, so that *glp-1(ts);skn-1(−)* animals exhibited markedly high levels of ORO staining ([Figure 5B,C](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). As an independent method of assessing fat accumulation in the intestine, we examined levels of the predicted short-chain FA dehydrogenase DHS-3 ([@bib116]). Proteomic and microscopy analyses have shown that DHS-3 localizes almost exclusively to intestinal lipid droplets ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}) and marks the vast majority of these lipid droplets in vivo ([@bib116]; [@bib73]). Consistent with ORO staining, lack of *skn-1* increased accumulation of a DHS-3::GFP fusion in the intestine in WT and GSC(−) animals, without affecting expression of the *dhs-3* mRNA ([Figure 5---figure supplements 2B,C](#fig5s2){ref-type="fig"}, [3](#fig5s3){ref-type="fig"}). An analysis of total triglyceride levels also indicated that SKN-1 reduces the overall level of fat accumulation ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}).

DAF-16 increases lipid accumulation in response to reduced IIS, and influences expression of some lipid metabolism genes in response to GSC removal ([@bib110]; [@bib64]). However, consistent with a previous study ([@bib78]), we found that loss of *daf-16* did not substantially affect overall fat storage in GSC(−) animals ([Figure 5D,E](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Together, our data indicate that SKN-1 is required to prevent excess fat accumulation under normal feeding conditions, and that SKN-1 but not DAF-16 reduces the lipid load that accumulates in response to GSC loss.

GSC loss activates SKN-1 through lipid signaling {#s2-6}
------------------------------------------------

Given that SKN-1 inhibits fat storage, we considered whether the SKN-1 activation seen in GSC(−) animals might be triggered by lipid accumulation. It is possible that GSC loss simply increases production of certain fats. However, GSC ablation or inhibition prevents formation of oocytes, which endocytose lipid-rich yolk that is synthesized in the intestine ([@bib35]). Fat storage might therefore be increased indirectly by GSC loss, through accumulation of unused yolk lipids. We tested a key prediction of this model by examining yolk accumulation and distribution, which can be visualized with GFP-tagged vitellogenin (YP170/VIT-2::GFP), a major yolk lipoprotein ([@bib35]). VIT-2::GFP was visible primarily in oocytes and embryos in WT day-1 adults but accumulated to extremely high levels throughout the body cavity in the absence of GSCs ([Figure 6A,B](#fig6){ref-type="fig"}, and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Apparently, yolk production was not slowed sufficiently to compensate for the lack of gametogenesis. The failure to consume yolk-associated lipid could account for the increase in overall fat storage seen in GSC(−) animals.10.7554/eLife.07836.015Figure 6.GSC absence activates SKN-1 through FA signaling.(**A**) Accumulation of yolk transporter VIT-2::GFP in the soma of GSC(−) animals. Detailed higher magnification images are provided in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. (**B**) COPAS quantification of VIT-2::GFP. Data are represented as mean ± SEM. (**C**) Knockdown of the oocyte-specific yolk receptor *rme-2* promotes somatic VIT-2 accumulation. (**D**--**F**) *rme-2* RNAi activates SKN-1 in the intestine. (**D**, **E**) SKN-1::GFP accumulates in intestinal nuclei in *rme-2* RNAi-treated worms. (**F**) In *rme-2* RNAi-treated worms, *gst-4p*::GFP levels in the intestine are increased at the L4 stage and increased further by day-1 adulthood. (**G**) *rme-2* RNAi enhances resistance to AS, in a *skn-1*-dependent manner (see replicates in [Table 2](#tbl2){ref-type="table"}). (**H**, **I**) An oleic acid (OA)-dependent signal is required for SKN-1 to be activated by GSC inhibition but not oxidative stress. In GSC(−) animals, SKN-1 nuclear accumulation is abolished by *sbp-1* RNAi and rescued by OA supplementation. SKN-1 remains capable of responding to oxidative stress (30 min AS exposure) after *sbp-1* RNAi in GSC(−) (**H**, **I**) or WT ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}) worms. (**J**) Dependence of SKN-1::GFP accumulation in GSC(−) animals on FAT-6/7-mediated FA desaturation, and proteins that generate free unsaturated FAs (LIPL-1/-3 lipases), or transport them to the nucleus (LBP-6/7/8). (**K**) OA and coconut oil (CO) increase *skn-1*-dependent *gst-4*p::GFP expression in the intestine. *lbp-8* RNAi reduces induction by OA. (**A**, **C**) Representative 10× GFP images. (**D**, **H**) Representative 40× GFP images of day-1 adults. (**E**, **F**, **I**--**K**) GFP quantification with high, medium, low scoring. Numbers above bars denote sample size. p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.015](10.7554/eLife.07836.015)10.7554/eLife.07836.016Figure 6---figure supplement 1.Enlarged VIT-2::GFP images.40× GFP and BF images of (**A**) GSC(+) and (**B**) GSC(−) animals are shown. Note that *glp-1(ts);*VIT-2::GFP is presented with 5× lower exposure times due to increased VIT-2::GFP intensity in GSC(−) animals. All worms shown are day-1 adults raised at 25°C. Arrowheads indicate the normal distribution of VIT-2::GFP in the intestine and oocytes, and arrows indicate the ectopic accumulation of VIT-2::GFP seen in GSC(−) animals. Numbers superimposed on images denote GFP exposure times.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.016](10.7554/eLife.07836.016)10.7554/eLife.07836.017Figure 6---figure supplement 2.SKN-1 is activated in response to FA signaling.Accumulation of SKN-1 in intestinal nuclei in (**A**) response to arsenite exposure for 30 min or (**B**) *daf-2* mutants is not impaired by *sbp-1* RNAi. (**C**) Effects of OA and CO doses on intestinal *gst-4p*::GFP expression, compared to AS treatment. (**D**) Larval development and (**E**) egg laying rate are not affected by OA or CO treatment. CO supplementation induces intestinal (**F**) SKN-1 nuclear accumulation but not (**G**) DAF-16 accumulation. (**H**, **I**) DAF-16 accumulation in *glp-1(e2141ts)* is unaffected by *sbp-1* RNAi. (**H**) Representative 40× DIC images of day-1 adults. (**J**) PMK-1 (p38 kinase) phosphorylation is not affected by GSC removal, consistent with a previous report ([@bib3]). PMK-1 phosphorylation is increased dramatically by AS oxidative stress and reflects activation of its kinase activity ([@bib42]). (**A**--**C**, **F**, **G**, **I**) GFP quantification with high, medium, low scoring. Numbers above bars denote sample size. p \< 0.05\*; p \< 0.01\*\*; p \< 0.001\*\*\*.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.017](10.7554/eLife.07836.017)10.7554/eLife.07836.018Figure 6---figure supplement 3.FA desaturation is required for GSC(−) stress resistance.*glp-1(ts)* and control day-1 adult worms treated with *lipl-3*, *sbp-1*, *fat-6/7* mix, *skn-1,* or empty vector RNAi were exposed to 5 mM AS. Knockdown of *lipl-3* (**A**, **B**), and either *sbp-1* (**A**, **B**) or *fat-6/7* (**C**, **D**) abolished the increase in AS resistance seen in *glp-1(ts)* animals. (**B**, **D**) Data are represented as mean ± SEM. p \< 0.05\*; p \< 0.01\*\*; p \< 0.001\*\*\*. The interaction between *glp-1(ts)* and *fat-6/7*, *lipl-3*, *sbp-1*, and *skn-1* were significant (p \< 0.001). Additional information and statistics are provided in [Table 2](#tbl2){ref-type="table"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.018](10.7554/eLife.07836.018)

We investigated whether accumulation of yolk-associated lipids might induce SKN-1 to mount a protective response. Supporting this idea, when the oocyte-specific yolk receptor *rme-2* is knocked down, yolk accumulates to high levels ([@bib35]), and in the intestine, SKN-1 accumulates in nuclei and its target gene *gst-4* is activated ([Figure 6C--F](#fig6){ref-type="fig"}). Additionally, *rme-2* RNAi increased stress resistance in a *skn-1*-dependent manner ([Figure 6G](#fig6){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). When de novo lipogenesis was prevented by knockdown of the SREBP1 ortholog *sbp-1* ([@bib113]), SKN-1::GFP failed to accumulate in intestinal nuclei in response to GSC inhibition ([Figure 6H,I](#fig6){ref-type="fig"}), but not oxidative stress ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}) or reduced IIS (*daf-2* mutants, [Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). The *sbp-1* lipogenesis defect can be rescued by supplementation with 600 µM OA ([@bib113]), which is the most abundant FA in olive oil, chicken egg yolk, and human adipose tissue ([@bib74]; [@bib50]). In *C. elegans*, the abundance of OA is increased in GSC(−) animals, and its synthesis by the FA desaturases, FAT-6 and FAT-7 (SCD orthologs), is required for GSC(−) lifespan extension ([@bib34]). *fat-6/7* were also required for SKN-1 to accumulate in nuclei after GSC inhibition ([Figure 6J](#fig6){ref-type="fig"}). Moreover, in GSC(−) animals subjected to *sbp-1* RNAi, SKN-1 nuclear accumulation was fully restored by OA supplementation ([Figure 6H,I](#fig6){ref-type="fig"}). Consistent with their importance for SKN-1 function, *sbp-1* and *fat-6/7* were required for GSC absence to increase stress resistance ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}).

Together, our data suggest that certain unsaturated lipids are required for SKN-1 to be activated in response to GSC loss, but not necessarily by other stimuli, and therefore, that lipid accumulation per se might activate SKN-1. Accordingly, feeding of either OA- or coconut oil (CO)-activated *gst-4* in WT animals in a *skn-1*-dependent manner without impairing development or reproduction ([Figure 6---figure supplement 2C--E](#fig6s2){ref-type="fig"}). Under these conditions, CO feeding provided OA (300 µM with 0.1% CO) along with multiple saturated FAs. CO feeding strongly induced nuclear accumulation of SKN-1 but not DAF-16 ([Figure 6---figure supplement 2F,G](#fig6s2){ref-type="fig"}), and *sbp-1* RNAi did not impair DAF-16 nuclear accumulation in GSC(−) animals ([Figure 6---figure supplement 2H,I](#fig6s2){ref-type="fig"}), supporting the notion that GSCs regulate SKN-1 and DAF-16 differently.

The lipid overload that results from reproductive failure might induce stress that activates SKN-1. Oxidative stress induced by sodium arsenite (AS) robustly activates the p38/PMK-1 kinase through phosphorylation, leading in turn to SKN-1 activation ([@bib42]). GSC loss induced SKN-1 nuclear accumulation at least as dramatically as AS treatment ([Figure 2B](#fig2){ref-type="fig"} and [Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}) but did not detectably increase PMK-1/p38 activity ([Figure 6---figure supplement 2J](#fig6s2){ref-type="fig"}), suggesting that any stress arising from the lack of GSCs might not be sufficient on its own to explain SKN-1 activation.

By breaking down triglycerides, the lysosomal lipases LIPL-1/3 and LIPL-4 enable production of specific unsaturated FFAs that promote autophagy and longevity ([@bib51]; [@bib76]; [@bib77]; [@bib26]). Some of these FAs are escorted from the lysosome to the nucleus by the conserved lipid-binding protein LBP-8/FABP1 ([@bib26]; [@bib36]). In GSC(−) animals, SKN-1 nuclear accumulation was inhibited modestly by *lipl-4* RNAi but more strongly by *lipl-1/3* double knockdown ([Figure 6J](#fig6){ref-type="fig"}). Furthermore, *lipl-3* RNAi reduced stress resistance in GSC(−) but not WT animals ([Figure 6---figure supplement 3A,B](#fig6s3){ref-type="fig"}). Given that fat storage is increased in *lipl-1/3* mutants ([@bib77]), our data suggest that in GSC(−) animals, SKN-1 activity may depend upon particular *lipl-1/3*-dependent products, not lipid levels per se. Knockdown of *lbp-8* or other LBPs also interfered with SKN-1::GFP nuclear accumulation in GSC(−) animals, and *lbp-8* RNAi impaired SKN-1-dependent *gst-4* activation by OA, indicating involvement of FA transport ([Figure 6J,K](#fig6){ref-type="fig"}). Together, our data suggest that in GSC(−) animals, excessive lipid levels lead to production of OA- and LIPL-1/3-dependent FAs that activate SKN-1, possibly through FA-based signaling ([Figure 7](#fig7){ref-type="fig"}).10.7554/eLife.07836.019Figure 7.SKN-1 regulation in the GSC longevity pathway.GSC absence results in activation of transcription factors in the intestine, with SKN-1 being regulated in parallel to DAF-12 and DAF-16. Yolk transport to oocytes is disrupted by GSC loss, resulting in lipid accumulation in the intestine and body cavity. The resulting SKN-1 activation requires OA, the FAT-6/7 FA desaturases, and the lysosomal lipases LIPL-1/3. This lipid-based signaling to SKN-1 depends partially upon LBP-8, which transports FAs from the lysosome to the nucleus. SKN-1 induces transcription of genes involved in stress resistance, detoxification, proteasome maintenance, extracellular matrix, and lipid metabolism, thereby reducing fat storage and increasing stress resistance and lifespan. Magenta denotes processes that are active in the presence of GSCs.**DOI:** [http://dx.doi.org/10.7554/eLife.07836.019](10.7554/eLife.07836.019)

Discussion {#s3}
==========

The question of how events in one tissue can influence aging in others is of fundamental importance. The effects of GSC loss in *C. elegans* provide a paradigm for investigating this problem, as well as interactions between a stem cell population and its environment. Here, we determined that GSC inhibition leads to a broad transcriptional reprogramming in somatic tissues that involves activation of SKN-1, and that SKN-1 is required for many beneficial effects of GSC absence, including lifespan extension. Previous work showed that SKN-1 is required for lifespan to be extended by reduced insulin/IGF-1, mTORC1, or mTORC2 signaling, by dietary restriction and by low-level mitochondrial reactive oxygen species (ROS) production ([@bib11]; [@bib108]; [@bib93]; [@bib115]; [@bib95]; [@bib68]; [@bib70]; [@bib24]). Our new data further support the idea that SKN-1/Nrf proteins are broadly important for longevity assurance.

One major role of SKN-1 in GSC(−) animals is to increase proteasome activity ([Figure 4C,D](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In WT animals, SKN-1 activates most proteasome subunit genes when the proteasome is inhibited ([@bib56]). This compensatory function is conserved in its mammalian ortholog Nrf1, which is cleaved and activated when proteasome activity is low ([@bib90]; [@bib103]; [@bib89]; [@bib96]). By contrast, in GSC(−) animals, proteasome activity is elevated ([Figure 4C,D](#fig4){ref-type="fig"}) ([@bib109]), suggesting that additional mechanisms influence SKN-1/Nrf regulation of proteasome genes. In GSC(−) animals, most if not all proteasome subunit genes are dependent upon SKN-1 for their expression ([Figure 4A](#fig4){ref-type="fig"}), and SKN-1 and DAF-16 together activate the proteasome subunit gene *rpn-6.1* ([Figure 4E,F](#fig4){ref-type="fig"}), the levels of which are rate limiting for proteasome activity ([@bib109]). Overexpression of either *rpn-6.1* or the 20S proteasome subunit *pbs-5* increases *C. elegans* lifespan, and in the latter case, lifespan extension was shown to be *skn-1*-dependent ([@bib109]; [@bib16]), suggesting that enhancement of proteasome activity may be an important mechanism through which SKN-1/Nrf promotes longevity.

The evidence that GSC(−) longevity is associated with fat accumulation, and altered lipid metabolism has raised the intriguing possibility that GSC absence induces production of lipids that promote health and longevity (see 'Introduction'). Our results are consistent with aspects of this model but suggest an important modification. GSC(−) animals accumulate dramatically high levels of yolk lipoproteins by the first day of adulthood ([Figure 6A,B](#fig6){ref-type="fig"}), providing a likely reason that they accumulate so much lipid. Moreover, SKN-1 acts to *reduce* fat accumulation but is critical for the benefits of GSC loss ([Figure 5B,C](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}), suggesting that GSC(−) animals do not simply overproduce healthful lipids. Finally, excess yolk accumulation induced by another method (*rme-2* RNAi) leads to increased SKN-1 nuclear accumulation and target gene activation, and *skn-1*-dependent stress resistance ([Figure 6D--G](#fig6){ref-type="fig"}). Taken together, our data suggest that GSC(−) animals accumulate excess fat because they cannot stop production of fat that would otherwise support reproduction ([Figure 7](#fig7){ref-type="fig"}). Importantly, however, in responding to and metabolizing this fat they produce specific lipids that activate SKN-1 and other regulators, which in turn increase lifespan and may promote a more healthy balance of lipids ([Figure 7](#fig7){ref-type="fig"}).

Several lines of evidence support this model. GSC inhibition induces SKN-1 and NHR-49 to upregulate largely distinct sets of FA oxidation genes ([Figure 5A](#fig5){ref-type="fig"}) ([@bib91]). This effect of SKN-1 could account for its inhibitory role in fat accumulation ([Figure 5B,C](#fig5){ref-type="fig"}). A need to metabolize excess fat could also explain the importance of lipophagy in GSC(−) longevity ([@bib51]; [@bib37]). With respect to signaling lipids, GSC(−) longevity requires the triglyceride lipase LIPL-4 ([@bib110]), which generates unsaturated FFAs that promote longevity ([@bib76]; [@bib26]). While LIPL-4-dependent FAs act through NHR-49 and NHR-80 ([@bib51]; [@bib26]), and possibly not SKN-1 ([Figure 6J](#fig6){ref-type="fig"}), in GSC(−) animals, SKN-1 activation involves the LIPL-1/3 lipases ([Figure 6J](#fig6){ref-type="fig"}), which also promote longevity ([@bib77]). This elevated SKN-1 activity also depends upon lipid transfer proteins, as well as OA ([Figure 6H--J](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). OA is required for GSC(−) longevity ([@bib34]) and is a precursor to unsaturated FAs that have signaling functions ([@bib76]; [@bib26]). Finally, SKN-1 upregulates *lipl-3* and *lbp-8* in WT and GSC(−) animals ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}; [Supplementary file 1a,c](#SD1-data){ref-type="supplementary-material"}), suggesting that it may function both downstream and upstream of lipid signals. The idea that SKN-1 can be activated by lipids that arise from prevention of reproduction and yolk consumption should be considered in evaluation of genetic or pharmacological interventions that increase SKN-1 activity.

SKN-1 is activated by lipids and regulates lipid metabolism gene expression not only in the high-fat GSC(−) model but also in WT animals under normal feeding conditions ([Figures 5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}; [Supplementary file 1b--d](#SD1-data){ref-type="supplementary-material"}). Moreover, SKN-1 profoundly reduced fat storage by the beginning of adult life in healthy, reproductively active animals that have not begun to age. Taken together, our findings suggest that SKN-1 plays an integral and direct role in maintaining lipid homeostasis. Our results predict that insufficient mammalian Nrf function does not lead to NAFLD/NASH simply by increasing chronic hepatic stress ([@bib112]; [@bib54]), and that a protective function of Nrf proteins in fat metabolism is likely to be involved. Nrf proteins therefore may provide an important line of defense against metabolic disease. Development of NAFLD is a growing obesity-related public health issue ([@bib17]). Our data suggest that analysis of Nrf proteins could be a promising underexplored direction for investigating causes and prevention of NAFLD, and that SKN-1 and *C. elegans* provide a genetically tractable model that will be valuable in this effort.

Our evidence that GSCs activate SKN-1 through lipid-based signaling suggests a new mechanism through which GSCs influence the soma. The response to GSC loss therefore involves metabolic signals that reflect the altered nutritional balance within the organism. Similar interactions could be important in other stem cell contexts. For example, in the mammalian bone marrow microenvironment, adipose tissue profoundly influences the function of hematopoietic and mesenchymal stem cells ([@bib2]; [@bib72]). In addition to the mechanisms we have described here, GSC(−) longevity involves endocrine signals from the somatic gonad and depends upon absence of GSCs per se, not simply reproductive cessation ([@bib46]; [@bib6]). It will now be of interest to determine how these mechanisms, as well as other transcription factors that are required for GSC(−) longevity (see 'Introduction'), interface with SKN-1 and its regulation.

Signaling lipids from endogenous, dietary, or microbiota sources constitute an area of considerable excitement, because these signals can induce beneficial effects such as anti-inflammatory protection, enhanced insulin sensitivity, protection against metabolic disease, and increased lifespan in *C. elegans* ([@bib110]; [@bib49]; [@bib60]; [@bib77]; [@bib26]; [@bib36]). Signals derived from OA are of particular interest in this regard, because of its dietary availability in olive oil. Mechanisms through which lipid signals are known to act on transcription networks include binding to nuclear receptors, and OA-induced protein kinase A activation that ultimately leads to FA oxidation ([@bib27]; [@bib60]; [@bib26]). By revealing SKN-1 as a new regulator of metabolism and stress defenses that is activated in response to lipids, our data suggest the exciting possibility that this might also be the case for mammalian Nrf proteins. They also suggest that a 'lipohormesis' pathway in which signaling lipids confer health benefits by activating SKN-1/Nrf may not only be a characteristic of GSC-ablated animals but also might be more broadly applicable for enhancing health- and possibly lifespan.

Materials and methods {#s4}
=====================

Strains {#s4-1}
-------

Worms were maintained on nematode growth medium (NGM) plates seeded with *Escherichia coli* (OP50) at 15°C, using standard techniques ([@bib13]). In all experiments, *glp-1(ts)* mutants were matched with the wild-type N2 strain used for outcrossing. The *C. elegans* strains used in this study are detailed in [Table 3](#tbl3){ref-type="table"}.10.7554/eLife.07836.020Table 3.*C. elegans* strains used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.07836.020](10.7554/eLife.07836.020)CodeGenetic backgroundTransgeneReferenceAA003*daf-12(rh61rh411)*\
X--([@bib99])AA983*glp-1(e2141ts)* III;\
*daf-12(rh61rh411)* X--([@bib99])AA1049*mir-241(n4315)* V;\
*mir-84(n4037)* X--([@bib99])AA1709*glp-1(e2141ts)* III;\
*mir-241(n4315)* V;\
*mir-84(n4037)* X--([@bib99])AA2735*glp-1(e2141ts)*\
III--([@bib99])CF1903*glp-1(e2141ts)*\
III--([@bib10])CF1935*daf-16(mu86)* I;\
*glp-1(e2141ts)* IIImuIs109\[*daf-16p::GFP::*\
*DAF-16* + *odr-1p::RFP*\] X([@bib10])CL2166N2dvIs19\[pAF15\
(*gst-4p::GFP::NLS*)\] III([@bib62])DH1033*sqt-1(sc103)* IIbIs1\[*vit-2p::VIT-2::*\
*GFP + rol-6(su1006)*\] X([@bib35])EU31*skn-1(zu135)*\
IV--([@bib12])LD001N2ldIs7\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]([@bib4])LD002N2ldIs1\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]([@bib4])LD1025*daf-2(e1370)*\
IIIldIs7\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]([@bib108])LD1425*glp-1(bn18ts)*\
IIIldIs1\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]This studyLD1434*glp-1(bn18ts)* III;\
*skn-1(zu135)* IV--This studyLD1473*kri-1(ok1251)* I;\
*glp-1(bn18ts)* IIIldIs1\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]This studyLD1474*tcer-1(tm1452)* II;\
*glp-1(bn18ts)* IIIldIs1\[*SKN-1b/c::*\
*GFP* + *rol-6(su1006)*\]This studyLD1548N2Is\[*dhs-3p::DHS-3::*\
*GFP*\] I([@bib116])LD1549*glp-1(bn18ts)*\
IIIIs\[*dhs-3p::DHS-3::*\
*GFP*\] IThis studyLD1644*sqt-1(sc103)* II;\
*glp-1(bn18ts)* IIIbIs1\[*vit-2p::VIT-2::*\
*GFP + rol-6(su1006)*\] XThis studyLD1653*glp-1(bn18ts)*\
III--([@bib21])\
Outcrossed from DG2389LD1744*glp-1(bn18ts)*\
IIIldEx119\[pAF15\
(*gst-4p::GFP::NLS*) + *rol-6(su1006)*\]This studyTJ356N2zIs356\[*daf-16p::*\
*DAF-16a/b::GFP + rol-6*\] IV([@bib39])

RNAi {#s4-2}
----

Feeding RNAi was performed using tetracycline-resistant HT115 bacteria carrying the pL4440 plasmid with ampicillin/carbenicillin resistance ([@bib44]). RNAi cultures were grown overnight in 50 ml conical tubes at 37°C with shaking at 220 RPM in 5 ml LB medium containing 50 µg/ml carbenicillin and 12.5 µg/ml tetracycline. Cultures were diluted 1:5 the following day in LB containing carbenicillin and tetracycline to allow for re-entry into the logarithmic growth phase, grown to an OD~600~ of 1.5 (∼6 hr). Cultures were centrifuged at 4500 RPM for 10 min, concentrated to a volume of 5 ml, and then induced with 1 mM IPTG prior to plating. Bacterial cultures were seeded onto standard NGM plates containing 50 µg/ml carbenicillin, 12.5 µg/ml tetracycline, and 0.4 mM IPTG.

Lifespans {#s4-3}
---------

Worms were synchronized by timed egg lay, upshifted to 25°C at the L2 stage, then scored for lifespan at 25°C or 20°C, as previously described ([@bib7]; [@bib93]). For analyses of *glp-1(ts)* at 20°C, worms were downshifted from 25°C upon reaching adulthood. Animals were transferred at the first day of adulthood to fresh plates containing FUdR (ACROS Organics/Thermo Fisher Scientific, Geel, Belgium) at a concentration of 100 µg/ml to inhibit progeny development ([@bib67]), unless otherwise indicated. RNAi-treated worms were placed on RNAi feeding plates starting at the first day of adulthood. Worms were maintained at a density of 30 worms per 6 cm plate on live bacteria and scored every other day. Animals that crawled off the plate, ruptured, or died from internal hatching were censored. Lifespans were graphed as Kaplan--Meier survival curves with JMP Pro 12 (SAS Institute, Middleton, MA). p values for survival curve analysis were generated using log-rank test. Additional statistical analysis was performed with GraphPad Prism 6 (GraphPad Software, La Jolla, CA). p values for mean lifespan analysis were calculated by two-way ANOVA with post hoc Holm-Šídák correction.

Stress assays {#s4-4}
-------------

Synchronized animals were incubated at 25°C during development then scored for survival hourly beginning at either days 1 or 3 of adulthood. Feeding RNAi was started at the L1 stage for day-1 stress assays or post-developmentally at day-1 adulthood for stress assays performed at day-3 adulthood. For the arsenite stress assay, worms were incubated in M9 buffer containing 5 mM AS (Riedel-de Haën, Seelze, Germany). For the tert-butyl hydroperoxide (TBHP) stress assay, worms were placed on solid NGM plates containing 15.4 mM TBHP (Sigma--Aldrich, St. Louis, MO). TBHP plates were freshly prepared on the day of the experiment. Survival assays were graphed as Kaplan--Meier survival curves with JMP Pro 12. p values for survival curve analysis were generated using log-rank test. Additional statistical analysis was performed with GraphPad Prism 6. p values for mean survival analysis were calculated by two-way ANOVA with post hoc Holm-Šídák correction.

Microscopy {#s4-5}
----------

Animals were anaesthetized for 5 min in 0.06% tetramisole/M9 buffer, mounted on 2% agarose pads on glass slides under coverslips, and imaged with ZEN 2012 software on an Axio Imager.M2 microscope (Zeiss, Jena, Germany).

GFP reporter scoring {#s4-6}
--------------------

Intestinal SKN-1::GFP nuclear localization and *gst-4p*::GFP::NLS expression were scored as 'high', 'medium', or 'low' as previously described ([@bib4]; [@bib24]). 'High' denotes strong intensity in all intestinal nuclei; 'medium' indicates relatively lower intensity or distribution in approximately half of intestinal nuclei; 'low' denotes weak or no visible GFP intensity in intestinal nuclei. p values were calculated by two-sided χ^2^ test.

Intestinal DAF-16::GFP nuclear localization was scored as 'high', 'medium', or 'low' as previously described ([@bib39]; [@bib10]; [@bib18]). 'High' denotes more DAF-16::GFP observed in the nucleus compared to the cytoplasm; 'medium' indicates animals with noticeable DAF-16::GFP in the nucleus but higher levels in the cytoplasm; 'low' denotes entirely cytoplasmic DAF-16::GFP.

SKN-1::GFP color isolation was performed to reduce gut granule autofluorescence using selective color matching against rgb(99,159,94) with a fuzziness setting of 125 and auto contrast in Adobe Photoshop CC 2014 (Adobe, San Jose, CA). DAF-16::GFP color isolation was similarly performed using selective color matching against rgb(0,255,111) with a fuzziness setting of 100.

qRT-PCR {#s4-7}
-------

Samples were prepared from ∼200 day-3 adult worms synchronized by timed egg lay. RNA was extracted using TRIzol (Thermo Fisher, Waltham, MA)-based phenol-chloroform extraction and purified with RNA Clean and Concentrator-5 spin columns (Zymo Research, Irvine, CA). RNA concentration and quality was assessed with a NanoDrop 1000 spectrophotometer (Thermo Fisher). cDNAs were prepared using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Thermo Fisher). mRNA levels were quantified from biological triplicates and technical duplicates using SYBR Green (Thermo Fisher) fluorescence on a 384-well format Real-Time PCR 7900 (Applied Biosystems, Foster City, CA). After an initial denaturation step (95°C for 10 min), amplification was performed using 40 cycles of denaturation (95°C for 15 s) and annealing (60°C for 1 min). Samples were analyzed by the standard curve method, with normalization to the reference genes *cdc-42* and Y45F10D.4 ([@bib40]). p values were calculated by two-sided Student\'s *t*-test with post hoc Holm-Šídák correction in GraphPad Prism 6. The primers used in this study are provided in [Table 4](#tbl4){ref-type="table"}.10.7554/eLife.07836.021Table 4.qRT-PCR primers used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.07836.021](10.7554/eLife.07836.021)GeneSequenceAnnotationPrimer pair*gst-4*K08F4.7Glutathione S-transferaseFWD: CCCATTTTACAAGTCGATGG\
REV: CTTCCTCTGCAGTTTTTCCAF20D6.11F20D6.11Flavin-adenine dinucleotide (FAD)-binding oxidoreductaseFWD: GGAAATTCTCGGTAGAATCGAA\
REV: ACGATCACGAACTTCGAACA*nit-1*ZK1058.6NitrilaseFWD: AATCCTCCGACTATCCCTTG\
REV: AGCGAATCGTTTCTTTTGTG*rpn-6.1*F57B9.1019S non-ATPase subunitFWD: AATATTGGAAAAGCACCTGAAATGT\
REV: TTTGATGTGGAAGTGAAGTCATTGT*lipl-3*R11G11.14Lysosomal triglyceride lipaseFWD: ATGGGCAGGCAAATCCACCA\
REV: AGTTGTTCTGCGCAATTATA\**cdc-42*R07G3.1Housekeeping geneFWD: CTGCTGGACAGGAAGATTACG\
REV: CTCGGACATTCTCGAATGAAG*\**Y45F10D.4Y45F10D.4Housekeeping geneFWD: GTCGCTTCAAATCAGTTCAG\
CREV: GTTCTTGTCAAGTGATCCGACA[^4]

RNA sequencing (RNA-seq) {#s4-8}
------------------------

Samples were prepared from ∼5000 synchronized, L1 arrested day-1 adult animals cultured at 25°C. Worms were synchronized by sodium hypochlorite (bleach) treatment, as previously described ([@bib86]). Bleach solution (9 ml ddH2O; 1 ml 1 N NaOH; 4 ml Clorox bleach) was freshly prepared before each experiment. Worms were bleached for 5 min, washed 5× in M9, and arrested at the L1 stage at 25°C in M9 containing 10 µg/ml cholesterol. Feeding RNAi was started at the L1 stage. This approach only partially reduces *skn-1* function but allows analysis of larger samples than would be feasible with *skn-1* mutants, which are sterile ([@bib12]). Because these animals were not treated with FUdR, the WT adults contained an intact germline and eggs. As is explained in the 'Results' section, we therefore confined our analysis to genes that were overrepresented in *glp-1(ts)* animals, which lack eggs and most of the germline, and established a high-confidence cutoff for genes that were upregulated by GSC absence as opposed to simply being expressed specifically in somatic tissues. RNA was extracted using the same protocol for qRT-PCR samples. Purified RNA samples were DNase treated and assigned an RNA Integrity Number (RIN) quality score using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Only matched samples with high RIN scores were sent for sequencing. Single read 50 bp RNA-seq with poly(A) enrichment was performed at the Dana-Farber Cancer Institute Center for Computational Biology using a HiSeq 2000 (Illumina, San Diego, CA).

FASTQ output files were aligned to the WBcel235 (February 2014) *C. elegans* reference genome using STAR ([@bib20]). These files have been deposited at the Gene Expression Omnibus (GEO) with the accession number GSE63075. Samples averaged 75% mapping of sequence reads to the reference genome. Differential expression analysis was performed using a custom R and Bioconductor RNA-seq pipeline (<http://bioinf.wehi.edu.au/RNAseqCaseStudy/>) ([@bib29]; [@bib5]; [@bib88]). Quantification of mapped reads in the aligned SAM output files was performed using featureCounts, part of the Subread package ([@bib57], [@bib58]). We filtered out transcripts that didn't have at least one count per million reads in at least two samples. Quantile normalization and estimation of the mean--variance relationship of the log counts was performed by voom ([@bib52]). Linear model fitting, empirical Bayes analysis, and differential expression analysis were then conducted using limma ([@bib100]). To identify genes that are upregulated in a SKN-1-dependent manner by GSC loss, we sought genes for which *glp-1(ts)* expression was higher than WT, and for which *glp-1(ts);skn-1(−)* expression was reduced relative to *glp-1(ts)*. To test for this pattern, if a gene\'s expression change was higher in the comparison of *glp-1(ts)* vs WT and lower in the comparison of *glp-1(ts);skn-1(−)* vs *glp-1(ts)*, then we calculated the minimum (in absolute value) of the *t*-statistics from these two comparisons, and assessed the significance of this statistic by comparing to a null distribution derived by applying this procedure to randomly generated *t*-statistics. We corrected for multiple testing in this and the differential expression analysis using the false discovery rate ([@bib9]). Heatmaps were generated using heatmap.2 in the gplots package ([@bib111]).

Functional annotations and phenotypes were obtained from WormBase build WS246. SKN-1 transcription factor binding site analysis of hits was conducted with biomaRt, GenomicFeatures, JASPAR, MotifDb, motifStack, MotIV, and Rsamtools ([@bib94]; [@bib22], [@bib23]; [@bib53]; [@bib81]; [@bib65]; [@bib97]). JASPAR analysis was performed with the SKN-1 matrix MA0547.1 using 2 kb upstream sequences obtained from Ensembl WBcel235 ([@bib101]). modENCODE SKN-1::GFP ChIP-seq analysis of hits was performed using biomaRt, ChIPpeakAnno, IRanges, and multtest ([@bib22], [@bib23]; [@bib30]; [@bib124]; [@bib75]; [@bib53]). SKN-1::GFP ChIP-seq peaks were generated by Michael Snyder\'s lab. We used the peak data generated from the first 3 larval stages: L1 (modENCODE_2622; GSE25810), L2 (modENCODE_3369), and L3 (modENCODE_3838; GSE48710). Human ortholog matching was performed using WormBase, Ensembl, and OrthoList ([@bib98]). Gene lists were evaluated for functional classification and statistical overrepresentation with Database for Annotation, Visualization, and Integrated Discovery (DAVID) version 6.7 ([@bib19]).

*rpn-6.1* binding site analysis {#s4-9}
-------------------------------

SKN-1 and DAF-16 binding peaks within the first intron and the promoter of *rpn-6.1* were previously identified by the modENCODE project ([@bib28]; [@bib30]; [@bib75]). We identified multiple hits with the consensus binding sequence ATCAT in the TRANSFAC matrices N\$SKN1_01 and N\$SKN1_02 using MATCH (Biobase, Wolfenbüttel, Germany) that overlap with the SKN-1::GFP ChIP-seq binding peaks within the first intron and the promoter of *rpn-6.1* ([@bib45]; [@bib63]). Our analysis also confirmed a previously identified hit ([@bib109]) in the N\$DAF16_01 matrix with the consensus binding sequence TGTTT that overlaps with the DAF-16::GFP ChIP-seq peak within the first intron. No putative DAF-16 binding sites were identified in the *rpn-6.1* promoter in the TRANSFAC MATCH analysis.

Proteasome activity {#s4-10}
-------------------

In vitro chymotrypsin-like proteasome activity assays were performed as previously described ([@bib48]; [@bib109]). Worms were bleach synchronized and maintained at 25°C from egg stage, then lysed at day 1 of adulthood, unless otherwise noted, in freshly prepared proteasome activity assay buffer (50 mM Tris--HCl, pH 7, 250 mM sucrose, 5 mM MgCl~2~, 0.5 mM EDTA, 2 mM ATP, and 1 mM dithiothreitol) using a Branson digital sonifier at 4°C. Lysates were centrifuged at 10,000×*g* for 15 min at 4°C. 25 µg of protein, calculated using the BCA protein assay (\#23225; Pierce Biotechnology/Thermo Fisher, Rockford, IL), was transferred to a flat 96-well microtiter plate (Nunc, Roskilde, Denmark). Samples were incubated at 25°C, and fluorogenic chymotrypsin substrate (\#230914; Calbiochem/EMD Millipore, San Diego, CA) was added to the plate immediately before analysis. Fluorescence (380 nm excitation; 460 nm emission) was measured every 3 min for 1 hr at 25°C using a Synergy MX microplate reader with Gen5 software (Bio-Tek, Winooski, VT). Lysates were assayed in triplicate. p values were calculated by two-sided Student\'s *t*-test in GraphPad Prism 6.

Fixed ORO staining {#s4-11}
------------------

ORO staining was performed on fixed animals, essentially as described ([@bib78]; [@bib114]), with some modifications. 200--300 day-1 adult worms synchronized by timed egg lay were washed three times with phosphate-buffered saline (PBS) then snap frozen in a dry ice/ethanol bath. Upon thawing, worms were treated with PBS containing 2% paraformaldehyde (PFA) (\#15713; Electron Microscopy Services, Hatfield, PA), using three freeze thaw cycles with dry ice/ethanol to permeabilize the cuticle. Worms were then washed with PBS to remove the PFA. Filtered ORO solution (0.5 g of ORO powder \[\#O0625; Sigma--Aldrich\] in 100 ml of 60% isopropanol) was prepared freshly before each experiment. Worms were stained for 3 hr in a round bottom 96 well plate in ORO solution at room temperature with gentle shaking. Longer staining periods, such as overnight incubation ([@bib78]), saturated ORO staining in *glp-1(ts)* animals to a level that rendered *glp-1(ts)* and *glp-1(ts);skn-1* strains indistinguishable.

Animals were imaged at 40× using differential interference contrast microscopy. Quantification of ORO staining was performed on the upper intestine, directly below the pharynx. Since ORO absorbs light at 510 nm (green channel), we performed background subtraction of the red channel from the green channel in Adobe Photoshop CC (Adobe) to specifically isolate the ORO staining, as previously described ([@bib114]). Quantification of mean intensity over background for each animal was performed using Fiji ([http://fiji.sc](http://fiji.sc/)). Statistical analysis was performed with GraphPad Prism 6. p values were calculated by one-way ANOVA with post hoc Holm-Šídák correction.

DHS-3::GFP scoring {#s4-12}
------------------

Using a COPAS Biosort (Union Biometrica, Holliston, MA) ([@bib87]), bleach-synchronized day-1 adult worms were scored for GFP fluorescence. RNAi was initiated after L1 arrest. The COPAS was used to record three attributes for each individual nematode: time of flight (TOF), which corresponds to nematode length; extinction (EXT), which corresponds to the optical density; and GFP fluorescence intensity. TOF and EXT measurements are related to the size and age of the nematode; both increase with development. These parameters were used to specifically gate adult worms. GFP fluorescence was normalized to worm size as a ratio of GFP/TOF values. Representative GFP images of each strain were captured at 4× using an Olympus IX51 inverted microscope (Olympus, New Orleans, LA). p values were calculated by one-way ANOVA with post-hoc Holm-Šídák correction in GraphPad Prism 6.

Triglyceride quantification {#s4-13}
---------------------------

Triglyceride (TAG) levels were measured with the Triglyceride Colorimetric Assay Kit (\#10010303; Cayman Chemical, Ann Arbor, MI). Samples were run according to the manufacturer\'s protocol in triplicate. TAG concentrations were normalized relative to protein concentration using the BCA protein assay (Pierce Biotechnology).
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\(a\) List of genes activated by GSC absence. The gene list is sorted by functional grouping, then by fold change of mRNA expression in *glp-1(ts)* relative to wild type. A fold change cutoff of 4 (p \< 0.05; n = 1306) was used (see [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} for rationale). A more conservative fold change cutoff of 5 that captured fewer genes (n = 615) was used for DAVID cluster analysis. FDR denotes false discovery rate. (b) List of genes activated by SKN-1 in wild-type animals. The gene list is sorted by functional grouping, then by fold change of mRNA expression in WT *skn-1* RNAi-treated worms relative to WT control vector-treated worms. A fold change cutoff of 0.67 (n = 295) was used to enrich for higher confidence SKN-1 targets. (c) List of genes activated by SKN-1 in GSC(−) animals. The gene list is sorted by functional grouping, then by fold change of mRNA expression in *glp-1(ts) skn-1* RNAi-treated worms relative to *glp-1(ts)* control vector-treated worms. A fold change cutoff of 0.67 (p \< 0.05; n = 529) was used to enrich for higher confidence SKN-1 targets. (d) List of genes activated by GSC absence in a SKN-1-dependent manner. The gene list is sorted by functional grouping, then by fold change of mRNA expression in *glp-1(ts) skn-1* RNAi-treated worms relative to *glp-1(ts)* control vector-treated worms. We employed a GSC(−) fold change cutoff of \>4 and *skn-1* RNAi cutoff of \<0.67 to generate the list (see [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} for GSC(−) FC cutoff rationale). Statistics were generated by min analysis. Predicted SKN-1 binding sites were determined using 1.5 kb upstream sequences from WBcel235 and the SKN-1 JASPAR matrix ([@bib101]). SKN-1::GFP ChIP-seq binding analysis was performed using the L1, L2, and L3 data sets available from modENCODE ([@bib75]). Additional details are available in 'Materials and methods'.

**DOI:** [http://dx.doi.org/10.7554/eLife.07836.022](10.7554/eLife.07836.022)

Major datasets {#s7}
--------------

The following dataset was generated:

Steinbaugh MJ,Dreyfuss JM,Blackwell TK,2015,RNA-seq analysis of germline stem cell removal and loss of SKN-1 in C. elegans,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63075>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE63075).

The following previously published datasets were used:

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2011,Identification of Transcription Factor SKN-1::GFP Binding Regions in L1,<http://intermine.modencode.org/release-33/report.do?id=77000137>,Publicly available at modMine (Accession no: modENCODE_2622).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2013,Identification of Transcription Factor SKN-1::GFP Binding Regions in L2,<http://intermine.modencode.org/release-33/report.do?id=77000379>,Publicly available at modMine (Accession no: modENCODE_3369).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2013,Identification of Transcription Factor SKN-1::GFP Binding Regions in L3,<http://intermine.modencode.org/release-33/report.do?id=77000500>,Publicly available at modMine (Accession no: modENCODE_3838).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2013,Identification of Transcription Factor SKN-1::GFP Binding Regions in L4,<http://intermine.modencode.org/release-33/report.do?id=77000600>,Publicly available at modMine (Accession no: modENCODE_4631).

Staab TA,Griffen TC,Corcoran C,Evgrafov O,Knowles JA,Sieburth D,2013,SKN-1 from the JASPAR CORE database,<http://jaspar.genereg.net/cgi-bin/jaspar_db.pl?rm=browse&db=core&tax_group=nematodes>,Publicly available at the JASPAR (Accession no: MA0547.1).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2011,Identification of Transcription Factor SKN-1::GFP Binding Regions in L1,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25810>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE25810).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2013,Identification of Transcription Factor SKN-1::GFP Binding Regions in L3,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48710>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE48710).

Zhong M,Snyder M,Slightam C,Kim S,Murray J,Waterston R,Gerstein M,Niu W,Janette J,Raha D,Agarwal A,Reinke V,Sarov M,Hyman A,2013,Snyder_SKN-1_GFP_L4,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46772>,Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSE46772).

10.7554/eLife.07836.041

Decision letter

Shen

Kang

Reviewing editor

Howard Hughes Medical Institute, Stanford University

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for sending your work entitled "Lipid-mediated regulation of SKN-1/Nrf in response to germ cell ablation" for consideration at *eLif*e. Your article has been favorably evaluated by K VijayRaghavan (Senior editor), a Reviewing editor, and two reviewers.

The reviewers found this manuscript interesting and potentially suitable for publication in *eLife*. For instance, one reviewer wrote: "This is an excellent, well written, and data-rich manuscript. Along the way, the authors correct findings published in several high profile papers by others and provide a refreshing interpretation of the nature of the lipid accumulation in *glp-1* mutants and the role of SKN-1 in response to this lipid overload. As such, it is a dramatic advance for a field that has generally ignored the role of intestinal yolk and simply interpreted all lipids in the intestine as the equivalent of adipose-like storage depots. The authors also do a thorough job of incorporating a variety of mutants that have been previously implicated in *glp-1* lifespan extension in the context of their studies."

Another reviewer wrote: "This study is very interesting because it explores the mechanism by which the conserved transcription factor NRF/SKN-1 acts to regulate longevity in response to deficiencies in the germline. This study also highlights an intriguing and novel germline-to-soma signaling for lifespan. Because SKN-1 is highly conserved throughout evolution and plays a role in metabolism in mammals, this study has important ramifications for age-related diseases in higher organisms. This study will appeal to a broad audience, including the fields of lipid metabolism, proteostasis, aging, and signaling."

However both reviewers raised some questions. Please address these comments in a revised version.

1\) The authors used "GSC ablation" and "*glp-1(ts)*" interchangeably throughout the text beginning with the Introduction. While *glp-1(ts)* worms are defective in GSC production, they still produce a partial germline, whereas worms that have undergone laser ablation of the germline would not produce GSCs at all. The authors should either tone done their terminology or for a few key assays, test worms that have undergone actual surgical ablation of the germline?

2\) [Figure 4D](#fig4){ref-type="fig"}: To make a statement regarding the role of *rpn-6.1* in regulating *glp-1(ts)* proteostasis or longevity in general, the authors should consider more functional tests. For example, is *rpn-6.1* required for *glp-1(ts)* longevity or for enhanced proteasome activity in *glp-1(ts)* worms.

3\) [Figure 6C](#fig6){ref-type="fig"}/D suggests that excessive accumulation of yolk fat may drive SKN-1 activations in the intestine. Would worms treated with *rme-2* RNAi, which presumably are high fat, exhibit high SKN-1 nuclear localization and beneficial phenotypes, such as stress resistance and longevity, associated with SKN-1 activation?

4\) [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}: The DHS-3 gene encodes a fatty acid dehydrogenase/reductase that targets the mitochondria. The DHS-3 marker likely reveals levels of short chain fatty acid breakdown. Though the quantification data correlate with the ORO staining pattern in [Figure 5B](#fig5){ref-type="fig"}/C very well, is DHS-3::GFP an accurate marker for lipid accumulation or lipid breakdown? In other words, are authors using lipid breakdown as a predictor of lipid accumulation in this case? Furthermore, are SKN-1 and SBP-1 regulators of *dhs-3* gene expression, where SKN-1 is a negative regulator and SBP-1 is positive regulator of *dhs-3*? If this is the case, one could expect a similar trend independently of lipid accumulation levels.

5\) Are genes encoding vitellogenin proteins upregulated at the mRNA level in somatic tissues of GSC(−) worms? This might provide insight into whether high somatic VIT-2 levels are directly due to failure of vitellogenin import into oocytes or a transcriptional consequence of GCS loss.

6\) While the overall point of the oil-red-o experiments is very convincing, there is a mismatch between the examples shown ([Figure 5B,D](#fig5){ref-type="fig"}) and the corresponding quantifications ([Figure 5C,E](#fig5){ref-type="fig"}). I recognize that this is really a problem of oil-red-o staining as it is not that suitable for quantification. One solution is to show a series of images for each condition in supplementary material so that the range of data can be seen. Alternatively (but not necessary), the authors can complement the studies by biochemical measurements of lipids.
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Author response

*1) The authors used "GSC ablation" and "*glp-1(ts)*" interchangeably throughout the text beginning with the Introduction. While* glp-1(ts) *worms are defective in GSC production, they still produce a partial germline, whereas worms that have undergone laser ablation of the germline would not produce GSCs at all. The authors should either tone done their terminology or for a few key assays, test worms that have undergone actual surgical ablation of the germline*?

We didn't intend to be misleading, but in hindsight agree that we should not have been so imprecise with terminology. While GSC ablation is a straightforward concept, *glp-1(ts)* animals raised at the non-permissive temperature exhibit a block in GSC proliferation, a dramatically reduced GSC number, and a failure of more mature germ cells to form. Unfortunately, the latter context is not so easily described by a simple term, and we are reluctant to use "*glp-1(ts)"* exclusively because it could make the manuscript less readable and accessible for readers who are not very familiar with *C. elegans*. To clarify things, we have modified the presentation of the work to explain in the Introduction how effects of GSC absence can be studied through either laser surgery, or genetic inhibition of GSC proliferation. We then explain that for simplicity we refer to either situation as "GSC(−) animals" or "GSC(−) longevity", and state clearly at the beginning of the Results that in this study our analyses involved use of *glp-1(ts)* mutants. We have removed the terms "ablated" and "ablation" where the meaning could be ambiguous, and where necessary for sentence flow instead used terms like GSC "inhibition" or "absence". I hope the editors will agree with us that this is a reasonable compromise that keeps the writing as simple as possible while avoiding being misleading.

*2)*[*Figure 4*D](#fig4){ref-type="fig"}*: To make a statement regarding the role of* rpn-6.1 *in regulating* glp-1(ts) *proteostasis or longevity in general, the authors should consider more functional tests. For example, is* rpn-6.1 *required for* glp-1(ts) *longevity or for enhanced proteasome activity in* glp-1(ts) *worms*.

We apologize for any lack of clarity, but we did not intend to make claims concerning the role of *rpn-6.1* in *glp-1(ts)* or longevity in general. Those models were previously published in the [@bib107] reference that we cited. With respect to *rpn-6.1*, we intended only to show only that its expression requires SKN-1, and that it is very likely to be a direct SKN-1 target. We have reorganized our presentation of our proteasome data accordingly, and have added evidence indicating that most if not all other proteasome subunit genes also appear to be activated by SKN-1 directly.

*3)*[*Figure 6*C*/D*](#fig6){ref-type="fig"}*suggests that excessive accumulation of yolk fat may drive SKN-1 activations in the intestine. Would worms treated with* rme-2 *RNAi, which presumably are high fat, exhibit high SKN-1 nuclear localization and beneficial phenotypes, such as stress resistance and longevity, associated with SKN-1 activation*?

We agree that these are good experiments. We have expanded our *rme-2* studies so that we now show that *rme-2* RNAi increases SKN-1::GFP nuclear localization, *skn-1-*dependent *gst-4p::GFP* activation, and *skn-1*-dependent stress resistance ([Figure 6D-G](#fig6){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). These observations fulfill a crucial prediction of our model that excessive yolk fat drives SKN-1 activation in GSC(−) animals.

*4)*[*Figure 5--figure supplement 1*](#fig5s1){ref-type="fig"}*: The DHS-3 gene encodes a fatty acid dehydrogenase/reductase that targets the mitochondria. The DHS-3 marker likely reveals levels of short chain fatty acid breakdown. Though the quantification data correlate with the ORO staining pattern in*[*Figure 5*B*/C*](#fig5){ref-type="fig"}*very well, is DHS-3::GFP an accurate marker for lipid accumulation or lipid breakdown? In other words, are authors using lipid breakdown as a predictor of lipid accumulation in this case? Furthermore, are SKN-1 and SBP-1 regulators of* dhs-3 *gene expression, where SKN-1 is a negative regulator and SBP-1 is positive regulator of* dhs-3*? If this is the case, one could expect a similar trend independently of lipid accumulation levels*.

In a study published 15 years ago, a computational algorithm predicted with 68% accuracy that the putative fatty acid hydrogenase/reductase DHS-3 localizes to mitochondria (WormBase annotation). Since then, an extensive series of proteomic and in vivo analyses in *C. elegans* have demonstrated conclusively that DHS-3 is instead present almost exclusively on the surface of intestinal lipid droplets, and marks the vast majority of these lipid droplets. This evidence includes a comprehensive set of experiments that were published in the [@bib114] paper that we referenced, as well as new studies from the same lab that have been published since our paper was initially submitted ([@bib73]). Both papers are referenced in the revised manuscript. These studies have experimentally validated DHS-3 as a marker of intestinal lipid droplets in vivo. The idea that this lipid metabolism enzyme is present almost exclusively on lipid droplets is consistent with the growing body of evidence that lipid droplets are complex organelles that incorporate many lipid metabolism enzymes, and act as hubs for multiple steps in lipid metabolism. It is appropriate to use DHS-3 as an indirect marker of fat storage, but we have examined its levels only as a backup modality to our oil-red-O staining. In the revised paper we have made this clear, and provided additional background about DHS-3.

With respect to expression of the *dhs-3* mRNA, the critical issue for our conclusions is whether its levels are regulated by GSCs, and dependent upon *skn-1*. Like numerous lipid metabolism enzymes, DHS-3 might be controlled by *sbp-1*, but we had added *sbp-1* RNAi to our analysis simply as a control, because it would call our conclusions into question if DHS-3 levels were not reduced by *sbp-1* knockdown. Our RNA-Seq data reveal that the relative representation of *dhs-3* mRNA in GSC(−) animals corresponds to the expectation for a somatic gene that is not regulated by GSCs (see discussion of somatic-specific mRNAs in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}). More importantly, we find that *dhs-3* expression is unaffected by *skn-1* RNAi in either WT or GSC(−) animals. This is now clearly shown and discussed (see [Figure 5--figure supplement 3](#fig5s3){ref-type="fig"}). These results are consistent with DHS-3 acting as an indicator of intestinal lipid accumulation, as is expected given its reliable presence in intestinal lipid droplets, rather than being upregulated by SKN-1 independently of lipid levels.

*5) Are genes encoding vitellogenin proteins upregulated at the mRNA level in somatic tissues of GSC(−) worms? This might provide insight into whether high somatic VIT-2 levels are directly due to failure of vitellogenin import into oocytes or a transcriptional consequence of GCS loss*.

Our RNA-Seq data indicate that the VIT genes are not transcriptionally upregulated in GSC(−) worms ([Figure 5--figure supplement 3](#fig5s3){ref-type="fig"}). Most are not present at increased levels at all, and certainly none of these mRNAs are preferentially represented in GSC(−) samples more than would be expected from any somatic-specific gene. This supports our model that the high somatic VIT-2 levels derive directly from failure of vitellogenin import.

*6) While the overall point of the oil-red-o experiments is very convincing, there is a mismatch between the examples shown (*[*Figure 5B,D*](#fig5){ref-type="fig"}*) and the corresponding quantifications (*[*Figure 5C,E*](#fig5){ref-type="fig"}*). I recognize that this is really a problem of oil-red-o staining as it is not that suitable for quantification. One solution is to show a series of images for each condition in supplementary material so that the range of data* can *be seen. Alternatively (but not necessary), the authors* can *complement the studies by biochemical measurements of lipids*.

This was a very good suggestion, and after looking more closely at our individual images we have adjusted our presentation of the ORO staining data in [Figure 5B,D](#fig5){ref-type="fig"} in order to more accurately reflect the middle ground for these images. Representative images with staining closer to the mean (graphed in [Figure 5C,D](#fig5){ref-type="fig"}) are now shown. To aid the reader in evaluating our staining, we have also compared these images to additional ones for each strain in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}. In this new supplemental figure, for each experimental condition five representative images that represent approximate quintiles of staining quantitation are ordered by lowest to highest staining. Next to each bright-field image is the background-subtracted image that shows the selected boundary of the upper intestine and quantification of that region (see ORO section in Methods for additional detail). Images are shown for *skn-1* mutant, *skn-1* RNAi, and *daf-16* mutant experiments. As an alternative method for assessing lipid accumulation, we consider DHS-3::GFP to be a reliable indirect indicator of intestinal lipid storage (see above), but we also confirmed that *skn-1* mutants have increased triglyceride levels using a colorimetric triglyceride assay kit ([Figure 5--figure supplement 2D](#fig5s2){ref-type="fig"}).

[^1]: Research Division, Joslin Diabetes Center, Boston, United States.

[^2]: Percent lifespan extension refers to *glp-1(ts)* vs wild type or *skn-1* control. p values were calculated by log-rank test. Symbols denote effect relative to N2\* or *glp-1(ts)*†. The interaction effect of *glp-1(ts)* and *skn-1* was calculated by two-way ANOVA using mean lifespan. The last p value reflects the specific requirement of *skn-1* for *glp-1(ts)* lifespan, as opposed to its effect on lifespan in general. Homozygous *skn-1* mutants produce eggs that do not hatch because of a catastrophic defect in developmental patterning but do not exhibit known defects in the germline itself ([@bib12]).

[^3]: Survival after sodium arsenite (AS) or tert-butyl hydroperoxide (TBHP) treatment was assayed in adult animals. The increase in oxidative stress resistance of *glp-1(ts)* germline stem cell (GSC(−)) animals was impaired by loss of *fat-6/7*, *lipl-3*, *sbp-1*, and *skn-1*. Representative assays are shown. Percent survival extension refers to *glp-1(ts)* or *rme-2* RNAi vs the matching wild type or *skn-1* control. p values were calculated by log-rank test. Symbols denote effect relative to N2\*, *glp-1(ts)*†, or *rme-2* RNAi‡. The interaction effect of GSC(−) or *rme-2* with *skn-1*, or *fat-6/7*, *lipl-3*, and *sbp-1* were calculated by two-way ANOVA using mean lifespan. The last p value reflects the specific requirement of each gene for GSC(−) or *rme-2* stress resistance as opposed to its effect on stress resistance in general.

[^4]: Select primer sequences were obtained from previous publications ([@bib93]; [@bib109]; [@bib77]).
